Richard T Silver, MD is Professor of Medicine, Attending Physician and Emeritus Director of the Richard T. SIlver M.D. Myleoproliferative Neoplasm Center at New York Presbyterian-Weill Cornell Medical Center. He is also Medical Director, The Cancer Research and Treatment Fund, Inc.; past President and current Member of the Board of Directors, New York State Society of Medical Oncologists and Hematologists; past President and currently Senior Advisor, Weill Cornell Medical College, Alumni Association, Life Member, Cornell University Council. Dr. Silver received his M.D. from Cornell University Medical College. He completed an internship in medicine and a residency in medicine (hematology) at The New York Hospital Cornell Medical Center. He was a Clinical Associate in the Leukemia Service of the General Medicine Branch at the National Cancer Institute, National Institutes of Health. Afterwards, he served as a Visiting Fulbright Professor at the University of Bahia, Salvador, Brazil. He then returned to The New York -Weill Cornell Medical Center where he has remained. Dr. Silver has combined a career of clinical investigation, teaching and practice. He draws patients from the large metropolitan New York City area and internationally. In his career, Dr. Silver has written more than 279 peer-reviewed articles, written or edited more than 4 books, more than 20 chapters, and 254 abstracts, and served on numerous review boards and study groups; belonged to over 13 medical societies; held 10 visiting professorships; delivered more than 200 invited national lectures and 50 international lectures. He has served as editor and reviewer of many medical journals and articles; He has been the principal investigator of numerous clinical trials; He served as Acting Chairman and Vice Chairman of Cancer and Leukemia Group B, a large multi-institutional cancer research group; in this group he served also as Chair of the Chronic Leukemia Subcommittee. Dr. Silver is routinely listed among The Best Doctors in New York and is listed in Who's Who in America, Who's Who in the World, Who's Who in Science, etc.

His current interests are in developmental therapeutics and evaluating small molecular drugs for treating chronic myeloid leukemia and the myleoproliferative neoplasms, polycythemia vera, essential thrombocythemia and primary myelofibrosis.